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ABSTRACT
The UvrB protein is one of the three subunits of the E. coli ABC exci-
nuclease. We have reported the sequences of the other two subunits, the UvrA
and UvrC proteins. In this paper the sequence of the UvrB protein is presented.
The protein sequence was determined from the DNA sequence of the uvrB gene and
was confirmed by sequencing the NH2-terminus of the UvrB protein and analyzing
its overall amino acid composition. The coding region of uvrB is 2019 basepairs,
specifying a protein of 672 amino acids and M of 76,118. The sequence of the
UvrB protein shows a moderate level of homology to that of the UvrC protein
and to the ATP binding site of the UvrA protein. During purification of UvrB
protein a proteolytic product, UvrB*, is produced in high quantities. We find
that UvrB* results from removal of about 40 amino acids from the COOH-terminus
of the UvrB protein. The uvrB gene has complex regulatory features. On the
5' side, the coding region is preceded by 3 promoters, a DnaA box and an SOS
box. On the 3' side the gene is followed by an REP (Repetitive Extragenic
Palindrome) sequence which has been implicated in gene regulation by an unknown
mechanism.
INTRODUCTION
ABC excinuclease of Escherichia coli is a DNA repair enzyme which removes
modified bases from DNA in the form of a 12-13 base-long oligonucleotide by
incising the damaged strand at the 8th phosphodiester bond 5' and the 4th or
5th phosphodiester bond 3' to the damaged nucleotide (1). The enzyme is made
up of three subunits, UvrA (103,866), UvrB (76,118) and UvrC (66,038) proteins.
We previously reported the sequences of the regulatory regions of all three
genes and the entire sequences of the UvrA and UvrC proteins as predicted from
the DNA sequences (2-5). In this communication we present the entire sequence
of the uvrB gene and the amino acid sequence predicted from the DNA sequence.
The amino acid sequence of the UvrB protein was confirmed by determining the
amino acid composition as well as the sequences of the NH2-termini of the
purified protein and that of its proteolytic product, UvrB* (6).
The uvrB gene is preceded by three promoters as reported previously (3),
has a coding region of 2019 base pairs encoding a protein of 672 amino acids
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and Mr = 76,118. The sequence of the UvrB protein shows several regions of
homology to that of the UvrC protein and a region homologous to that of the
UvrA protein's presumptive ATP binding site. The coding region of uvrB is
followed by a 25 bp hyphenated palindrome located 37 bp 3' to the termination
codon. The palindrome, which probably acts as a transcriptional termination
signal, has the consensus sequence of the REP (repetitive extragenic palindromic)
sequences and therefore may act in regulating uvrB expression by an additional
mechanism (see Ref. 7 for a review) that encompasses at least 25 other E. coli
genes, including uvrD.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. E. coli K12 strains DR153 (zecA uvrB)
and DH1 (recA hsdR ) were used to maintain and isolate the uvrB plasmid,
pUNC20, as the source of the uvrB gene in this study. pUNC20 was constructed
as follows: pDR1494, which contains a 5.7 kbp chromosomal fragment carrying
the uvrB gene (8) was first digested with Bgl I, and then with the Bal3l
exonuclease to remove approximately 1id bp from the termini of the Bgl.I
fragments. Following the removal of Bal3l nuclease by phenol extraction Bam
HI linkers were ligated to the now blunt-ended Bgl I fragments and the 3.4 kbp
fragment carrying the uvrB gene was purified by polyacrylamide gel electrophore-
sis followed by electroelution. This fragment was inserted into the Bam HI
site of pBR322 to obtain pUNC20 (uvrB bia tet ). This plasmid complemented
the uvrB deletion mutation of DR153 (8) and after the initial isolation in
that strain it was propogated in DH1 (9). Plasmid DNA from this latter strain
was isolated by Sarkosyl lysis and CsCl-ethidium bromide density centrifugation.
DNA Sequencing. The 3.4 kbp Bam HI fragment of pUNC20 was isolated and
mapped with the restriction enzymes Bgl II, Bst NI, Hae III, Hinf I, Pvu II
and Rsa I. The restriction fragments were terminally labeled at 5' ends using
polyaucleotide kinase and sequenced by the method of Maxam and Gilbert (10).
Sequence Analysis. The amino acid sequence of the UvrB protein was
compared to those of the UvrA and UvrC protein using the ALIGN program from
the Protein Identification Resource of the National Biomedical Research Founda-
tion (11). The sequence of the UvrB protein was also compared to the protein
sequences in the National Biomedical Research Foundation Protein Sequence
Library using the FASTP program of Lipman and Pearson (12).
Protein Chemistry. The UvrB protein was purified as described previously
(6). The UvrB* polypeptide was purified from the side fraction of the F2 step
of the UvrB purification procedure (6). The details of the purification of
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Fig. 1. Restriction Map of the uvrB plasmid pUNC20 used in this study. The
vector sequence is speckled. The location and direction of transcription of
the uvrB gene is indicated by the heavy arrow.
UvrB* and of its properties will be published elsewhere (M. Levy and A. Sancar,
in preparation). The sequences of the NH2,-termini of the UvrB and UvrB*
proteins were determined by Dr. C. Noyes of the University of North Carolina
using a Beckman 890 C Sequencer. The amino acid composition was obtained from
analysis of acid hydrolysates on a Beckman 121M amino acid analyzer. Cysteine
and methionine were quantitated as cysteic acid and methionine sulfone from
performic acid oxidized protein.
RESULTS
Sequencing of the uvrB Gene. The uvrB gene was previously identified in
the Clarke-Carbon E. coli gene library (13) and subcloned into pBR322 on a 5.6
kbp-long Pst I fragment (8). Further restriction mapping of this fragment
showed that the gene was surrounded on either side by Bgl I sites outside of
the the uvrB gene. This fragment was digested with Bai3l, joined to Bam HI
linkers and inserted into pBR322 to obtain pUNC20 (Figure 1). To sequence the
gene the Bam HI fragment carrying uvrB was purified and mapped with restriction
enzymes. Terminally labeled fragments were purified and sequenced by the
method of Maxam and Gilbert (10) as outlined in Figure 2. About 90% of the
gene was sequenced in both strands and all the restriction sites used for
terminal labeling within the gene were crossed by a sequence obtained from a
fragment generated by a different restriction enzyme.
Sequence of the uvrB Gene. The promoter-operator region of uvrB was
sequenced and the transcriptional and translational start points were determined
2639
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Fig. 2. Sequencing strategy for the uvrB gene. In this figure only the
cutting sites of the restriction enzymes whose sites were mapped throughout
the 3.4 kbp chromosomal fragment are shown. In addition to these enzymes Hin
P1, Fnu 4HI, Nci I, Sau 3A and Ava II were used for generating fragments for
terminal labeling and/or for cutting of terminally labeled fragments. The
arrows indicate the direction and length of sequences obtained from the corres-
ponding restriction sites.
previously (3). This previously published sequence as well as the rest of the
uvrB gene sequence obtained in this work is shown in Figure 3. The gene is
preceded by three promoters: P1, P2 and P3. Transcription from P3 terminates
within the P2 sequence in vitro whereas transcriptions from P1 and P2 continue
into the coding region. P3 overlaps with a DnaA box (14) and P2 with an SOS
box (3). Transcription from P2 is inhibited by LexA protein in vitro (3) and
in vivo (15) while transcription from P1 is not inhibited by LexA protein in
vitro (3) but may be in vivo (15). The translational start point is at +34
(with regard to the P1 transcriptional start point). The open reading frame
starting at this point continues for 673 codons terminating at a TM at bp
+2053. The protein encoded by this open reading frame has a calculated Mr =
76,118 (excluding the first Met), in reasonable agreement with the MHr reported
for the UvrB protein based on its migration in sodium dodecylsulfate polyacryla-
mide gels (8). The open reading frame is followed, 37 bp 3' to the termination
codon, by a 25 bp hyphenated palindrome which presumably acts as a transcrip-
tional terminator (16). It is interesting to note that this potential termina-
tion signal matches the consensus sequence for REP (repetitive extragenic
palindrome) that has been found outside the coding regions of about 25 other
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CRCATCICCTCACCtACCATTC_ B TCCCCTCCCCCACCACACCGTTACTTGGCGCTGCTGGCTCAGCGAUACCTTCACCATTGCCAATGTCA?TTCTGACCTTCACG
L eAArAlOPh lysP pa*rlomonreOlluAl&llSlSvatlugLaluj WuABpa;llmaNisOWhrlyA*Wv lrhzlys-rgolyysrhrPh*rhrZleAlaA nV I]olaAlpL,Wn
250 300 350
XCCCCAACCATCCACTTCCCCCAACA^AACGCTGCCCcscAGCTGTATGcGeMATG4ucArATTcTTcccGGAAAzAcGcerGGcAATAmcTTTCCACCTACcoTACGCATATcCCCAGCCGGAAGCTATGTACTcGAmCAcACTTTC
AnroThrttV IL4larerlA ldingrL~AlyAAlagnLu7ysOJVuNpthshOuPAlFvProluAwAlValalurgrPrrwrAsprTrryrAsnp7rVOnro OluAlaJrg rVlroSerSrsprr
400 450 500
ATTGAGAAAGATOCCCTC AGWTATACGTGCCTTCTCGCCACCAAAGCGATGCTC,GAGCGCGcTGATCTGGTTGTGGTGCGcTCTGTCCGCGATTATGGTCTGGGCGATCCTGAATTTTACTCTAAGATGATCCTC
IOIULgSAplaSrValAsnluJ1wtiZleluanotaorgLsdrAlarhrLVAlattuoJluArgApvAlvalValVaIV&AJ S*rV&IS*rA]AZIarwrIybuOIyAspiProAspLL4u7V LgWsttS LUe
550 600 650
CATCTCAC¢sGTAcTGTATTATCGATCAacGGscGATTcT¢C¢CC¢ACTGCGGsAGCTGCAATACGCTCGTAATGACcArmcAGcGTGGTAcm eTTTccG mTGGcGAGGTGATAGATATCTTCsCCGOAGAATcOGATGAcATT
lisuhrValGlgfttZlZIoApO]nAIVAz]IlargALxLuAJaGluL1nrydrAl ArgAsspoInAlaPhdGlnAr,gGJVThrPh ArgV lArgGVGIUVlZvlo& spZlorh troAlaGOlSrAASPZpll
700 750 g00
GCACMTCGTCrGAlTACTGMGCGAGACAGTGGACGATTGTTCGrACGACCTCGccCTACCGGAGATTGTc TTTCCACAcTTCCATCGII AcCCATTCCAAAAccCACGCACTACGCACACCGCGCGGCGCATCGTACAGCGATGGAG
AJLAUrgV lOluLOuPhoAMpGJJluOV IGIuAr,glS*rAmt*spProhruO]yJolnZIev 15errhrZIoProArgPllarhriloryrProLysrhzWisRrVValrhrPr*ArfoluArgZIeV JIGnAldotOlu
850 900 950
G¢ATCA7C GCAGCTGCCGCCAGCGCAAATGCTGTGAAACAACAMC ACTGCTGGcAcAGACcs cAGCGG TGACCCACGTCCAGrTGTATCTGAATGcAcTGCGAGCTGGTA CTGTTC GGGGATTTGAMCTACTCGCGCTTC
OliluZILpOuOlu-yL4aIaArArgAyVaILouLoluAsnAsnLysLuLoualLiluaInArgL uhroIGnArg7hrGlnJ'h AspLoUolun#tJltAsnGluL uolyryrCysSorOlgZII luAsnrvr erArgthe
1000 1050 1100
CTMCTCCCTCFGACC¢GGTGAGCCACCGCCGACGCTCTTTCArTACCT¢CCTGCCGATGGGCTGCTGGTCGTCGATGMATCTCACCTCACCATTCCACAAATTGCGGCCATGTATCGCCCTCACCCCCGGCGCTAAAGAGACACT¢CT¢GAG
L uSrjOlyArgOlyProOlyOluprotroProThrLouhespTyrL uProAJ AspalyLouLuv IV&IAspGluSorHisValfhrZJ*ProGlnZIIdlyOlyll tTyrArgGlyAspArgAIaArgLysalurhrLeuVlal0u
1150 1200 1250
TACGGCTTCCGCCTGCCATCAGCCCCTGGATACCGTCCGCTTAAGTTTGAAGCTTCGAAGCATTAGCGCCGCAAACCTCATCTGTTTCGGCGACGCCGGGTAATTACGAGCTGGAAMATCCGGCGGCGATGTGGTGGATCAGGTGGT¢CC;T
ryrGlyPh ArgLouroS*rAlpLwAspnw4rgtroL uLyjs hdlu01u hoOluIuAlPmaroGJnThrZlaryrV&ISerAlaThrProGlVAxnryrG]uL uGluLy ssrG]yG]yAspValValAspOinV IV IArgr
1300 1350 1400
CCAA~CCCCTTGCSGACCCGATTATCGCMCT¢CGCCGGCTGCGCACACAGGTTGATGATCTTCTTCGGACATTCGTCAGCCAGCGCAATTAACGAACGCGTACTGGTCACCACACTGACCAACGGCATGCGGAAGCATCTTACCGAATAT
ProThrGlyLeuLeuAproZIoZIo luValArgProValAloThr(;nV lAspAspL*uL&S*rGluZI¢ArgGlnArgAI Al*IleAsnGluArgV lL uvaIrhrThrL uJhrLy Argx tAl aluAmpL uThrOluryr
1450 1500 1550
CTCAAGAACATGGCGAGCGCGTGCGTTATCTTCGCTCAGATATCGACACCCTCGACGCTATGGAGATTATCCGCGACTTGCGTCTGGCCTGAGTTCGACGTGCTGGTACGGACAACTTACTGCGCGAAGGTCTGGTTCCGGCCTCTCG
L ualuglLdli NlpluAzrg lArgryrL uArgS*rAspZI Asprhrv GLALuArgfttaluZIoZIArgAspL uA4rx7L uGl)GuPh AspV&lL*uValGlIVl*AsnoL*uArgOluGlyL uAsplbt:PreOouVaISor
1600 1650 1700
CTGGCTGCGATCCTCGACGCTGACAAAGAAGCTTCCT¢CCSTCCGAACCSTCGTTGATCCAGACCATTGGTCGTGCCGCACGTAACGTTAACGGTAAACGCATTCTCTACGCGSATMAGATCACCCCATCAATGGCGAAAGCGATTGCGCCM
L ~uVaIAlaIloL4uAspAl AspLysoluolyPhLur,gSzaluArgVS*rL uZIodlnThrZI alVArgrAl AIaArgAsnVaIAsnr,IVLysAIAIleL uryrOlyAspLysIleTrProS*rlbtA LabJAI&II lpoylu
1750 1800 1850
ACCGAACGTCGCCGGAGAAACAGCAGAAGTACAACGAGGAACACGGAATTACGCCGCAAGGCTMGAACAAGAATGGTCGATATCCTGGCGCTGGGG;CAGAACATTGCCAAAACCAAACGCGAAGCAGAGGAAATCGCGCCCCGATTGTT
I'h alLuArgAr,gArgG]uLysaG nalnLysryrAsnOluGluNisOlyZI rhrProGInGlyL uAsnLysLVsV&I VaIAspI leL uLAlaL ur,iyonAsnZIIAl LysThrLysA] LV901VArgGl yLysSrArgrProZJl*VaI
1900 1950 2000
GAGCCGGATAATGTGCCGATGGATATGTCGCCTAAAGCGTTGCAGCAGAAAATCCATGAGCTGGAAGGGTTGATCATGCACACCGCGCAGAATCTGGAGTTCGAAGAAGCGGCGCAAATTCGTGACCACTTGCATCAGCTGCGTGAGCTCTTT
GJuProAspAsnV lProNhtAspNot.SrProLysAJl AlnGlnLysIl NfisGluLoAluGlyLoNtntGlrnUisAI aGInAsnLoGluPhdGluGluAl AlaGlnZI ArgAspGlnLHuisGlnL uArgoluLouPhe





Fig. 3. Sequences of the uvrB gene and protein. The -10 and -35 sequences
of the three promoters (P1, P2, P3), the three transcriptional start sites
(Si, S2, S3) and the LexA binding site ("SOS box") as well as the DnaA binding
site ("DnaA box") are indicated. The ribosome binding site is marked by a
double overline and the REP sequence by the two opposing arrows. The potential
cleavage site of the protein that results in production of UvrB* is indicated
by the broken arrow.
E. coli genes including uvrD (7, 17-19). This sequence is presumed to be
involved in gene regulation by some novel mechanism (17). As this sequence,
with the exception of stable RNA genes, is found only in extragenic regions of
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the E. coli chromosome, we conclude that the uvrB gene constitutes a single-gene
transcriptional unit (operon).
Protein Chemistry of UvrB Protein. To confirm the amino acid sequence of
the UvrB protein predicted from the DNA sequence we analyzed the UvrB protein
purified to homogeneity (1, 6). Amino acid sequencing yielded NH2-Ser-Lys-Pro-
Phe-Lys-Leu-Asx as the first 7 N-terminal amino acids indicating that the
N-formylmethionine is removed from the NH2-terminus of the mature protein.
This sequence is in agreement with the amino acid sequence predicted from the
nucleotide sequence in Figure 3 and is the same as the sequence we reported
previously (3), even though in our previous report there was a discrepancy
between the DNA sequence and the protein sequence due to a typographical error
in recording the DNA sequence (see 20). Further confirmation of the UvrB
protein sequence came from the analysis of the amino acid composition of the
purified protein. The result obtained is compared to the predicted composition
in Table 1. There is a good agreement between the compositions suggesting
that the amino acid sequence shown in Figure 3 is the correct sequence of the
UvrB protein. An interesting feature of the UvrB subunit according to the DNA
sequence is the absence of Trp in the protein. Accordingly, the protein
should have an absorption maximum at 275 nm and not at 280 nm as comonly is
the case with an average protein. This was found to be the case as there was
good agreement between the experimentally determined relative absorbance
values at these two wavelengths and the predicted values (data not shown).
Thus, the spectrophotometric analysis lends further support to the UvrB protein
sequence predicted from the DNA sequence.
During purification of the UvrB protein from overproducing cells 80-90%
of the overproduced protein is cleaved at a specific site immediately following
cell lysis to produce a protein (UvrB*) of MrH 70,000 (6). The same phenomenon
is observed in maxicells as well, indicating that a great level of overproduc-
tion is not necessary for this cleavage. However, we have no indication that
cleavage occurs at all in vivo either in overproducing or wild type cells and
therefore we doubt if this cleavage has any physiological significance.
Nevertheless the cleavage site might be a hinge point in the polypeptide chain
and its localization may be of importance in studying the structure-function
relationship of the UvrB protein. We, therefore, determined the NH2-terminal
sequence of IJvrB* to localize the cleavage site. The sequence of the first
seven N-terminal amino acids were the same as those of intact UvrB protein
suggesting that UvrB* resulted from the removal of about 40 amino acids from
the COOH-terminus of the protein. It is interesting to note that this cleavage
2642
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Table 1. Amino Acid Composition of UvrB Protein
Predicted From Found by
Amino Acid DNA Sequence Amino Acid Analysis*
Asx 61 (Asp 40 + Asn 21) 59
Thr 34 33
Ser 30 28
















*Based on a molecular weight of 76,118 for the UvrB protein.
results in a great loss of activity with regard to the nucleolytic function of
ABC excinuclease.
Codon Usage in UvrB Protein. In E. coli it has been found that codons
corresponding to rare cognate tRNAs are used rarely in highly expressed genes
and more frequently in low copy-usually regulatory-proteins (21, 22). While
the suggestion that this type of codon usage may play a role in translational
regulation (22,23) has been questioned (see 24), it is generally accepted that
there is a correlation between the abundance of a particular protein and the
lack of rare codons in its gene. Therefore it was of interest to tabulate the
codon usage in the UvrB protein and compare it to those of the other two
subunits of ABC excinuclease, the UvrA and UvrC proteins. It has been reported
2643
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that an uninduced E. coli cell contains about 25 molecules of UvrA protein
(5,25), 150-200 molecules of UvrB protein (8) and 10 molecules of UvrC protein
(26). Table 2 shows the codon usage in the three proteins. As we reported
previously (4,5) rare codons are used frequently in the UvrC but not in the
UvrA protein. The UvrB protein, as expected from its moderately high level
does not contain rare codons at high frequency (Table 3). This finding, in
turn, supports our earlier conclusion, based on the relative intensities of
UvrA and UvrB bands in maxicells that the uvrB protein is relatively abundant
in an uninduced E. coli cell (8). It is of interest to note that the AGC
codon for Ser which occurs at a frequency of about 20-30 percent in all reported
E. coli proteins including UvrA and UvrC, is not utilized in the UvrB protein.
Sequence Homology Between the Uvr Proteins. We compared the sequence of
the UvrB protein to those of the UvrA (5) and UvrC (4) proteins. The UvrA and
UvrB proteins do not share significant sequence homology. However, the UvrB
protein has a region (residues 39-53) that has the consensus Walker "A type"
ATP binding sequence G-X4-GKT-X6-I (27). Two such sequences have been found
in the UvrA protein (5) and in Figure 4 one of these sequences is compared to
that found in the UvrB protein. The homology is not more than expected for
two ATPases that contain Walker's A type sequence. The interesting fact is
that while the UvrA protein is a bone fide ATPase the UvrB protein is not,
even though it stimulates the ATPase activity of the UvrA protein by a factor
of 2.5 in the presence of DNA (6). Whether the UvrB protein has any ATP
binding activity remains to be determined.
The UvrB and UvrC proteins contain regions of homology that are scattered
throughout both proteins; however, the distribution of the homologous regions
is such that the two proteins cannot be aligned. In Figure 4 we present the
two regions of both proteins that show the most extensive homology. It is of
interest to note that the 14-amino acid stretch that is 12 amino acids from
the COOH-terminus of the UvrB protein is homologous (13 out of 14) to a region
in the middle of the UvrC protein.
DISCUSSION
The E. coli ABC excinuclease of E. coli is made up of 3 subunits which
probably do not associate with one another in the absence of substrate. When
the subunits (UvrA, UvrB and UvrC) are mixed with damaged DNA they assemble
sequentially to constitute ABC excinuclease which removes the damaged bases in
a 12-13 base-long oligonucleotide. To identify the functional domains of each




UvrA (28-45) V L S L A F D
UvrB (39-53) 6 - - T I A N
UvrB (318-360) P P P T L F D Y L P A D G L L V V D e sH V T I P Q I G G N Y AR K E T
UvrC (292-334) I L L D F N L S D K T L L A D S L S D L A G R K I N V Q T K P|R G D R A R|Y L K
UvrB (641-672) N Q H A N LtF EE AAQI R D L H QLELF I A A S***
UvrC (192-223) D T A S N L E F E E A ARI R D I Q A VJR A V T E K Q
Fig. 4. Sequence homologies between the Uvr proteins. The region of the
UvrB protein that has homology to Walker's consensus ATP binding site is
compared to one of the two potential ATP binding sites in the UvrA protein
(5). The circled amino acids are the ones conserved in Walker's consensus
sequence. Also shown in the figure are two regions in the UvrB and UvrC
proteins that show the most extensive homology. There are other regions of
moderate homology whose significance is uncertain. ***, the COOH-terminus of
the UvrB protein.
sequences of the UvrA and UvrC proteins were reported previously (4,5) and in
this paper we have presented the sequences of the uvrB gene and protein.
The uvrB gene sequence reported here as well as the promoter-operator
sequence reported previously (3) indicate that the uvrB gene by itself consti-
tutes a transcriptional unit and is not part of a larger operon. However, as
was reported previously (3,28) it is one of the genes of the SOS regulon and
is perhaps subject to transcriptional regulation by other regulatory circuits
(2). Regarding the regulation of the uvrB gene the following points are
worthy of consideration. First, the gene is preceded by three promoters, P1,
P2 and P3 that start transcription at +1 (33 bp upstream from the initiation
codon), -31 and -342 bp, respectively. P1 seems to be transcribed constitu-
tively in vitro (3) and partially repressed by the LexA protein in vivo (15).
P2 overlaps with a SOS box and is inhibited by the LexA repressor strongly
both in vitro (3) and in vivo (15). The transcript of P3 terminates within
the SOS box even in the absence of LexA protein in vitro, and in the presence
of the repressor the transcriptional start from this promoter is inhibited by
some unknown mechanism since the LexA protein does not bind to P3 with any
measurable affinity. Second, the AATTTGTGTCATAATTAA sequence overlapping the
Pribnow box of the uvrA promoter is homologous to the sequence AATTTGTTGGGATAA
TTAA that overlaps the -35 sequence of P1 and the Pribnow box of P2 of uvrB
gene suggesting that this sequence may be the recognition site for a protein
that regulates these two genes by a mechanism separate from the SOS response
(2). Third, a DnaA protein recognition sequence homologous to that found in
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oriC overlaps the -35 sequence of P3 (14). That this sequence does function
as a DnaA binding site in vivo is suggested by the fact that cells containing
multicopy plasmids carrying the P3 promoter fail to grow in minimal medium (8)
but do grow in a dnaAts background under permissive conditions (29). In
addition to these complex regulatory structures found on the 5' side of uvrB
there is a Repetitive Extragenic Palindrome (REP) located 37 bp downstream
from the termination codon. Although the REP sequences are widespread in the
E. coli chromosome (7,18) their exact function is not known. Nevertheless, it
has been found that deletions of REP sequences 3' to the S. typhimurium hisJ
gene (18) and 3' to the E. coli gdhA gene (7) decrease the expression of the
corresponding upstream genes. We, therefore, propose that the expression of
the uvrB gene is influenced by the REP sequence as well as the LexA and DnaA
proteins.
The coding region of the uvrB gene is 2019 basepairs specifying a protein
of 672 amino acids and M = 76,118. The amino acid predicted from the DNA
r
sequence has been confirmed by sequencing the amino terminus of the protein
and determining its amino acid composition. These studies also revealed that
the initiation codon f-Met is removed from the mature protein as amino acid
sequence analysis shows that the UvrB protein starts with a Ser residue, the
second amino acid predicted from the DNA sequence. The protein has a somewhat
unusual composition in that it lacks Trp, and even though the protein contains
about equal numbers of positively and negatively charged (at pH 7.0) residues
it is an acidic protein having a pI 5.0 (data not shown), perhaps because of
differential solvent accessibility of these residues.
The codon usage in the UvrB protein is like that of moderately expressed
proteins, in line with our previous reports that there were about 200 molecules
of UvrB protein in wild type E. coli (8). With regard to codon utilization
UvrB is similar to the UvrA protein even though in uninduced cells there are
about 10-fold as many UvrB molecules as UvrA molecules. However, DNA damaging
treatments that elicit the SOS response produce approximately the same levels
bf both proteins (30) and this might explain why rare codons are not utilized
in UvrA protein. On the other hand rare codons are utilized at high frequency
in the UvrC protein whose constitutive level is about 10 molecules per cell
(26) and is induced slightly (31) or not at all (32) by SOS treatments.
The UvrB protein sequence obtained in this study was compared to the
sequences of the UvrA and UvrC proteins. There was no significant homology
between the UvrA and UvrB proteins, but surprisingly the UvrB protein - which
has no ATPase activity - was found to contain Walker's consensus "A type
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sequ!nce" (27) found in many ATPases including the UvrA protein. At present
we have no explanation for the presence of this sequence. The UvrB protein is
known to stimulate the ATPase activity of the UvrA protein in the presence of
DNA (6). While it is possible that this effect is brought about by a conforma-
tional change resulting from binding of the UvrB protein to the UvrA-DNA
complex, it is conceivable that the UvrB protein is an ATP binding protein
that becomes an ATPase only in the UvrA-UvrB-DNA ternary complex. Further
studies are needed to determine whether the UvrB protein binds ATP and whether
only the A subunit or both the A and B subunits function as ATPases in the
UvrA-UvrB-DNA complex.
Several regions of homology were detected between the UvrB and UvrC
proteins. At present it is difficult to speculate on the evolutionary or
functional significance of this homology as the distribution of the homologous
regions in the two proteins precludes alignment of the two subunits along
their full length and the functions of the individual subunits of the ABC
excinuclease in'the excision reaction are not known at present. It is of
interest to note that the region of most extensive homology is that near the
C-terminus of the B subunit and in the middle of the C subunit. It is also of
importance to point out that the UvrB* protein which is missing this region of
homology has lost most but not all of the B activity as measured by the specific
incision of UN irradiated DNA (data not shown).
We do not know whether the specific cleavage of the UvrB protein to
produce UvrB* has any physiological significance. As we pointed out before we
have no evidence that this cleavage occurs in vivo (6). Regarding the mechanism
of cleavage, we do not think it is self proteolysis as we do not observe the
cleavage with the purified UvrB protein. We are more inclined to think that
this cleavage is caused by a specific E. coli protease. The amino acid sequence
of the UvrB protein shown below is homologous to one of the two cleavage sites
found in the Ada protein (32, I.A. Teo, personal communication) and cleavage.




Arrows show the cleavage site in the Ada protein and the potential cleavage
site in the UvrB protein. Further studies are needed to determine whether
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